356 related articles for article (PubMed ID: 22558197)
1. Tau-mediated nuclear depletion and cytoplasmic accumulation of SFPQ in Alzheimer's and Pick's disease.
Ke YD; Dramiga J; Schütz U; Kril JJ; Ittner LM; Schröder H; Götz J
PLoS One; 2012; 7(4):e35678. PubMed ID: 22558197
[TBL] [Abstract][Full Text] [Related]
2. Motor neuron TDP-43 proteinopathy in progressive supranuclear palsy and corticobasal degeneration.
Riku Y; Iwasaki Y; Ishigaki S; Akagi A; Hasegawa M; Nishioka K; Li Y; Riku M; Ikeuchi T; Fujioka Y; Miyahara H; Sone J; Hattori N; Yoshida M; Katsuno M; Sobue G
Brain; 2022 Aug; 145(8):2769-2784. PubMed ID: 35274674
[TBL] [Abstract][Full Text] [Related]
3. Aberrant interaction between FUS and SFPQ in neurons in a wide range of FTLD spectrum diseases.
Ishigaki S; Riku Y; Fujioka Y; Endo K; Iwade N; Kawai K; Ishibashi M; Yokoi S; Katsuno M; Watanabe H; Mori K; Akagi A; Yokota O; Terada S; Kawakami I; Suzuki N; Warita H; Aoki M; Yoshida M; Sobue G
Brain; 2020 Aug; 143(8):2398-2405. PubMed ID: 32770214
[TBL] [Abstract][Full Text] [Related]
4. SFPQ and Tau: critical factors contributing to rapid progression of Alzheimer's disease.
Younas N; Zafar S; Shafiq M; Noor A; Siegert A; Arora AS; Galkin A; Zafar A; Schmitz M; Stadelmann C; Andreoletti O; Ferrer I; Zerr I
Acta Neuropathol; 2020 Sep; 140(3):317-339. PubMed ID: 32577828
[TBL] [Abstract][Full Text] [Related]
5. Detection of Alzheimer's disease (AD) specific tau pathology with conformation-selective anti-tau monoclonal antibody in co-morbid frontotemporal lobar degeneration-tau (FTLD-tau).
Gibbons GS; Kim SJ; Robinson JL; Changolkar L; Irwin DJ; Shaw LM; Lee VM; Trojanowski JQ
Acta Neuropathol Commun; 2019 Mar; 7(1):34. PubMed ID: 30832741
[TBL] [Abstract][Full Text] [Related]
6. Constitutive Dyrk1A is abnormally expressed in Alzheimer disease, Down syndrome, Pick disease, and related transgenic models.
Ferrer I; Barrachina M; Puig B; Martínez de Lagrán M; Martí E; Avila J; Dierssen M
Neurobiol Dis; 2005 Nov; 20(2):392-400. PubMed ID: 16242644
[TBL] [Abstract][Full Text] [Related]
7. [Aberrant Interaction Between FUS and SFPQ in Neurons in a Wide Range of FTLD Spectrum Diseases].
Ishigaki S
Brain Nerve; 2021 Sep; 73(9):1021-1028. PubMed ID: 34462374
[TBL] [Abstract][Full Text] [Related]
8. Level of PICALM, a key component of clathrin-mediated endocytosis, is correlated with levels of phosphotau and autophagy-related proteins and is associated with tau inclusions in AD, PSP and Pick disease.
Ando K; Tomimura K; Sazdovitch V; Suain V; Yilmaz Z; Authelet M; Ndjim M; Vergara C; Belkouch M; Potier MC; Duyckaerts C; Brion JP
Neurobiol Dis; 2016 Oct; 94():32-43. PubMed ID: 27260836
[TBL] [Abstract][Full Text] [Related]
9. Neuropathology of frontotemporal lobar degeneration-tau (FTLD-tau).
Dickson DW; Kouri N; Murray ME; Josephs KA
J Mol Neurosci; 2011 Nov; 45(3):384-9. PubMed ID: 21720721
[TBL] [Abstract][Full Text] [Related]
10. Altered Tau Isoform Ratio Caused by Loss of FUS and SFPQ Function Leads to FTLD-like Phenotypes.
Ishigaki S; Fujioka Y; Okada Y; Riku Y; Udagawa T; Honda D; Yokoi S; Endo K; Ikenaka K; Takagi S; Iguchi Y; Sahara N; Takashima A; Okano H; Yoshida M; Warita H; Aoki M; Watanabe H; Okado H; Katsuno M; Sobue G
Cell Rep; 2017 Jan; 18(5):1118-1131. PubMed ID: 28147269
[TBL] [Abstract][Full Text] [Related]
11. Frontotemporal lobar degeneration FTLD-tau: preclinical lesions, vascular, and Alzheimer-related co-pathologies.
Thal DR; von Arnim CA; Griffin WS; Mrak RE; Walker L; Attems J; Arzberger T
J Neural Transm (Vienna); 2015 Jul; 122(7):1007-18. PubMed ID: 25556950
[TBL] [Abstract][Full Text] [Related]
12. Dysregulation and Dislocation of SFPQ Disturbed DNA Organization in Alzheimer's Disease and Frontotemporal Dementia.
Lu J; Shu R; Zhu Y
J Alzheimers Dis; 2018; 61(4):1311-1321. PubMed ID: 29376859
[TBL] [Abstract][Full Text] [Related]
13. Preferential tau aggregation in von Economo neurons and fork cells in frontotemporal lobar degeneration with specific MAPT variants.
Lin LC; Nana AL; Hepker M; Hwang JL; Gaus SE; Spina S; Cosme CG; Gan L; Grinberg LT; Geschwind DH; Coppola G; Rosen HJ; Miller BL; Seeley WW
Acta Neuropathol Commun; 2019 Oct; 7(1):159. PubMed ID: 31640778
[TBL] [Abstract][Full Text] [Related]
14. GFP-Mutant Human Tau Transgenic Mice Develop Tauopathy Following CNS Injections of Alzheimer's Brain-Derived Pathological Tau or Synthetic Mutant Human Tau Fibrils.
Gibbons GS; Banks RA; Kim B; Xu H; Changolkar L; Leight SN; Riddle DM; Li C; Gathagan RJ; Brown HJ; Zhang B; Trojanowski JQ; Lee VM
J Neurosci; 2017 Nov; 37(47):11485-11494. PubMed ID: 28986461
[TBL] [Abstract][Full Text] [Related]
15. Altered distribution of RhoA in Alzheimer's disease and AbetaPP overexpressing mice.
Huesa G; Baltrons MA; Gómez-Ramos P; Morán A; García A; Hidalgo J; Francés S; Santpere G; Ferrer I; Galea E
J Alzheimers Dis; 2010; 19(1):37-56. PubMed ID: 20061625
[TBL] [Abstract][Full Text] [Related]
16. Glial reactivity and T cell infiltration in frontotemporal lobar degeneration with tau pathology.
Hartnell IJ; Woodhouse D; Jasper W; Mason L; Marwaha P; Graffeuil M; Lau LC; Norman JL; Chatelet DS; Buee L; Nicoll JAR; Blum D; Dorothee G; Boche D
Brain; 2024 Feb; 147(2):590-606. PubMed ID: 37703311
[TBL] [Abstract][Full Text] [Related]
17. Glycogen synthase kinase-3 is associated with neuronal and glial hyperphosphorylated tau deposits in Alzheimer's disease, Pick's disease, progressive supranuclear palsy and corticobasal degeneration.
Ferrer I; Barrachina M; Puig B
Acta Neuropathol; 2002 Dec; 104(6):583-91. PubMed ID: 12410379
[TBL] [Abstract][Full Text] [Related]
18. Development of a novel tau propagation mouse model endogenously expressing 3 and 4 repeat tau isoforms.
Hosokawa M; Masuda-Suzukake M; Shitara H; Shimozawa A; Suzuki G; Kondo H; Nonaka T; Campbell W; Arai T; Hasegawa M
Brain; 2022 Mar; 145(1):349-361. PubMed ID: 34515757
[TBL] [Abstract][Full Text] [Related]
19. Astrocytes expressing hyperphosphorylated tau protein without glial fibrillary tangles in argyrophilic grain disease.
Botez G; Probst A; Ipsen S; Tolnay M
Acta Neuropathol; 1999 Sep; 98(3):251-6. PubMed ID: 10483782
[TBL] [Abstract][Full Text] [Related]
20. Tau pathology in frontotemporal lobar degeneration with C9ORF72 hexanucleotide repeat expansion.
Bieniek KF; Murray ME; Rutherford NJ; Castanedes-Casey M; DeJesus-Hernandez M; Liesinger AM; Baker MC; Boylan KB; Rademakers R; Dickson DW
Acta Neuropathol; 2013 Feb; 125(2):289-302. PubMed ID: 23053135
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]